Hrustanovic, Gorjan <br/><br/>
RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.  [electronic resource] 

 -  Nature medicine  Sep 2015 
 - 1038-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1546-170X 
<br/><br/><label>Standard No.: </label>10.1038/nm.3930  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anaplastic Lymphoma Kinase<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm<br/>Dual Specificity Phosphatase 6--physiology<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors<br/>Mitogen-Activated Protein Kinases--physiology<br/>Oncogene Proteins, Fusion--analysis<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>ras Proteins--genetics